-
Analysis of Pharmacists' Awareness on Post COVID-19 Conditions and Implementation in Postgraduate Education in Ukraine
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Cervical Cancer Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Incidence of Neutropenia Adverse Events Identified in Electronic Healthcare Records Among Initiators of CDK4/6 Inhibitors With Advanced Breast Cancer in the UK
Sep 9, 2025, 16:22 PM -
The Burden and Management of Flares Among Pregnant Patients With Generalized Pustular Psoriasis (GPP): Real-World Evidence (RWE) From the Global SCRIPTOR Study
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Access and Pricing Timelines for Innovative Medicines in the US, Europe, and Japan Pre- and Post-Pricing Reform 2021-2025
Sep 9, 2025, 16:22 PM -
Beyond Leave-One-Out: A Ranked Leave-k-Out Method for Detecting Influential Studies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Oteseconazole vs. Fluconazole for Patients With Severe Vulvovaginal Candidiasis in China
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on PD-L1 Testing and Use of Immuno-Oncology (IO) Treatments Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Hospital Burden of Pulmonary Arterial Hypertension in France: A Real-World Study Using the French Hospitalization Database (PMSI)
Sep 9, 2025, 16:22 PM -
Health Technology Assessments of Oncology Orphan and Advanced Therapies: The Case for Incorporating Real-World Evidence Patient-Reported Outcomes and Indirect Treatment Comparisons Into Joint Clinical Assessment Submissions
Sep 9, 2025, 16:22 PM -
Children With Asthma Receiving Dupilumab Plus Medium-Dose Inhaled Corticosteroids Had Improved Exacerbations, Lung Function, and Airway Inflammation Compared To Those Receiving Placebo Plus High-Dose Inhaled Corticosteroids
Sep 9, 2025, 16:22 PM -
Bimekizumab Led to Sustained Improvements in Health-Related Quality of Life and Work Productivity in Patients With Axial Spondyloarthritis: 3-Year Results From Two Phase 3 Studies
Sep 9, 2025, 16:22 PM -
Fractional Polynomial Survival Models in HTA: An Exploratory Review of Use and Methodological Guidance Across Global Agencies
Sep 9, 2025, 16:22 PM -
Evaluation of Health-Related Quality of Life (HRQoL) Among Patients Treated With Lifileucel After Progression on Immune Checkpoint Inhibitors (ICIs) and Targeted Therapies: Analyses From the C-144-01 Trial
Sep 9, 2025, 16:22 PM -
The Impact of Annual Price Revision Based on External Reference Pricing on Medicines Between 2012 and 2023 in Portugal
Sep 9, 2025, 16:22 PM -
Regulatory Landscape Challenges and Trends in the Adoption of Digital Endpoints in Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the United Arab Emirates
Sep 9, 2025, 16:22 PM -
Decoding Atorvastatin-Induced Arthritis: A Systems Pharmacology Approach Integrating Pharmacovigilance, Bioinformatics, and Pathway Enrichment
Sep 9, 2025, 16:22 PM -
Strengthening Routine Childhood Immunization Post-COVID: Global Strategies to Improve Coverage and Equity
Sep 9, 2025, 16:22 PM -
Evaluating High-Cost Gene Therapies for Noncancer Conditions: Insights From NICE's Standard Appraisal Process
Sep 9, 2025, 16:22 PM
